182 related articles for article (PubMed ID: 20109579)
21. Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.
Suzuki K; Oneyama C; Kimura H; Tajima S; Okada M
J Biol Chem; 2011 May; 286(18):15698-706. PubMed ID: 21388951
[TBL] [Abstract][Full Text] [Related]
22. Histone onco-modifications.
Füllgrabe J; Kavanagh E; Joseph B
Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
[TBL] [Abstract][Full Text] [Related]
23. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
24. Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1.
Aihara H; Nakagawa T; Mizusaki H; Yoneda M; Kato M; Doiguchi M; Imamura Y; Higashi M; Ikura T; Hayashi T; Kodama Y; Oki M; Nakayama T; Cheung E; Aburatani H; Takayama KI; Koseki H; Inoue S; Takeshima Y; Ito T
Mol Cell; 2016 Oct; 64(1):176-188. PubMed ID: 27716482
[TBL] [Abstract][Full Text] [Related]
25. RAS signalling in the colorectum in health and disease.
Poulogiannis G; Luo F; Arends MJ
Cell Commun Adhes; 2012 Feb; 19(1):1-9. PubMed ID: 22233291
[TBL] [Abstract][Full Text] [Related]
26. Global histone modification of histone H3 in colorectal cancer and its precursor lesions.
Nakazawa T; Kondo T; Ma D; Niu D; Mochizuki K; Kawasaki T; Yamane T; Iino H; Fujii H; Katoh R
Hum Pathol; 2012 Jun; 43(6):834-42. PubMed ID: 21917293
[TBL] [Abstract][Full Text] [Related]
27. Fast signals and slow marks: the dynamics of histone modifications.
Barth TK; Imhof A
Trends Biochem Sci; 2010 Nov; 35(11):618-26. PubMed ID: 20685123
[TBL] [Abstract][Full Text] [Related]
28. RAS oncogene-mediated deregulation of the transcriptome: from molecular signature to function.
Schäfer R; Sers C
Adv Enzyme Regul; 2011; 51(1):126-36. PubMed ID: 21094659
[TBL] [Abstract][Full Text] [Related]
29. [The significance of histone modifications in malignant transformation].
Gomulak P; Błasiak J
Postepy Biochem; 2012; 58(3):292-301. PubMed ID: 23373415
[TBL] [Abstract][Full Text] [Related]
30. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells.
Yoh KE; Regunath K; Guzman A; Lee SM; Pfister NT; Akanni O; Kaufman LJ; Prives C; Prywes R
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6107-E6116. PubMed ID: 27681615
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.
Wang Y; Shang Y
Exp Cell Res; 2013 Jan; 319(2):160-9. PubMed ID: 22935683
[TBL] [Abstract][Full Text] [Related]
32. Levels of histone acetylation in thyroid tumors.
Puppin C; Passon N; Lavarone E; Di Loreto C; Frasca F; Vella V; Vigneri R; Damante G
Biochem Biophys Res Commun; 2011 Aug; 411(4):679-83. PubMed ID: 21763277
[TBL] [Abstract][Full Text] [Related]
33. Regulation of CBP and Tip60 coordinates histone acetylation at local and global levels during Ras-induced transformation.
Sánchez-Molina S; Estarás C; Oliva JL; Akizu N; Asensio-Juan E; Rojas JM; Martínez-Balbás MA
Carcinogenesis; 2014 Oct; 35(10):2194-202. PubMed ID: 24853677
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of activated Ras suppresses multiple oncogenic Hub genes in human epithelial tumors.
Cao L; Wang P; Luo H; Wang XR; Wang XF; Zhang JX; Wang YY; Yao L; Liu N; You YP
Int J Oncol; 2014 Oct; 45(4):1609-17. PubMed ID: 24993178
[TBL] [Abstract][Full Text] [Related]
35. Influence of inositol hexaphosphate on the expression of selected proliferation markers in IL-1β-stimulated intestinal epithelial cells.
Kapral M; Sośnicki S; Wawszczyk J; Węglarz L
Acta Pol Pharm; 2014; 71(6):987-93. PubMed ID: 25745771
[TBL] [Abstract][Full Text] [Related]
36. The landscape of histone acetylation involved in epithelial-mesenchymal transition in lung cancer.
Zhang L; Liu Z; Ma W; Wang B
J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S86-91. PubMed ID: 24135248
[TBL] [Abstract][Full Text] [Related]
37. Ras-ERK signalling represses H1.4 phosphorylation at serine 36 to promote non-small-cell lung carcinoma cells growth and migration.
Shi S; Zhang J; Liu M; Dong H; Li N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2343-2351. PubMed ID: 31184227
[TBL] [Abstract][Full Text] [Related]
38. Genomic instability and histone H3 phosphorylation induction by the Ras-mitogen activated protein kinase pathway in pancreatic cancer cells.
Espino PS; Pritchard S; Heng HH; Davie JR
Int J Cancer; 2009 Feb; 124(3):562-7. PubMed ID: 19004007
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.
Su H; Jin X; Shen L; Fang Y; Fei Z; Zhang X; Xie C; Chen X
Tumour Biol; 2016 Apr; 37(4):5355-63. PubMed ID: 26561473
[TBL] [Abstract][Full Text] [Related]
40. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
